Assign Clinical Research Joins Celerion

Effective January 1, 2016, Assign Clinical Research, headquartered in Vienna, Austria, joined Celerion. Celerion is the global leader in early clinical research, with a focus on Applied Translational Medicine. Assign conducts early stage clinical studies, as well as specialized later stage studies, across a broad range of therapeutic areas with a particular focus in oncology, vaccines, cancer immunotherapy, personalized medicine and autoimmune disorders.  

For additional information, please visit www.celerion.com.